Tevogen Bio Holdings Inc (NASDAQ:TVGN) has a beta value of -1.09 and has seen 4.05 million shares traded in the last trading session. The company, currently valued at $236.32M, closed the last trade at $1.35 per share which meant it lost -$0.03 on the day or -2.17% during that session. The TVGN stock price is -1462.22% off its 52-week high price of $21.09 and 80.74% above the 52-week low of $0.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.51 million shares traded. The 3-month trading volume is 3.85 million shares.

Tevogen Bio Holdings Inc (NASDAQ:TVGN) trade information

Sporting -2.17% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TVGN stock price touched $1.35 or saw a rise of 14.01%. Year-to-date, Tevogen Bio Holdings Inc shares have moved 31.07%, while the 5-day performance has seen it change 11.57%. Over the past 30 days, the shares of Tevogen Bio Holdings Inc (NASDAQ:TVGN) have changed 35.54%. Short interest in the company has seen 3.69 million shares shorted with days to cover at 0.09.

Tevogen Bio Holdings Inc (TVGN) estimates and forecasts

The company’s shares have gained 90.76% over the past 6 months.

TVGN Dividends

Tevogen Bio Holdings Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Small Cap Index Fund and iShares Russell 2000 Growth ETF . As of Oct 31, 2024 , the former fund manager holds about 0.13% shares in the company for having 226.32 shares of worth $0.31 million while later fund manager owns 145.9 shares of worth $0.2 million as of Oct 31, 2024 , which makes it owner of about 0.08% of company’s outstanding stock.